| First Author | Ma H | Year | 2016 |
| Journal | Cancer Lett | Volume | 376 |
| Issue | 2 | Pages | 293-302 |
| PubMed ID | 27080303 | Mgi Jnum | J:231903 |
| Mgi Id | MGI:5775485 | Doi | 10.1016/j.canlet.2016.04.011 |
| Citation | Ma H, et al. (2016) MicroRNA-17~92 inhibits colorectal cancer progression by targeting angiogenesis. Cancer Lett 376(2):293-302 |
| abstractText | The miR-17~92 microRNA (miRNA) cluster host gene is upregulated in a broad spectrum of human cancers including colorectal cancer (CRC). Previous studies have shown that miR-17~92 promotes tumorigenesis and cancer angiogenesis in some tumor models. However, its role in the initiation and progression of CRC remains unknown. In this study, we found that transgenic mice overexpressing miR-17~92 specifically in epithelial cells of the small and large intestines exhibited decreased tumor size and tumor angiogenesis in azoxymethane and dextran sulfate sodium salt (AOM-DSS)-induced CRC model as compared to their littermates control. Further study showed that miR-17~92 inhibited the progression of CRC via suppressing tumor angiogenesis through targeting multiple tumor angiogenesis-inducing genes, TGFBR2, HIF1alpha, and VEGFA in vivo and in vitro. Collectively, we demonstrated that miR-17~92 suppressed tumor progression by inhibiting tumor angiogenesis in a genetically engineered mouse model, indicating the presence of cellular context-dependent pro- and anti-cancer effects of miR-17~92. |
